Integra gains access to competitors technology for $65M

Dave Pearson | | Health Imaging | Enterprise Imaging
Integra LifeSciences, a maker of implants and medical devices used in orthopedics, neurosurgery and general surgery, has purchased Ascension Orthopedics of Austin, Texas, for $65 million in cash.

Integra is headquartered in Plainsboro, N.J., and develops technologies for the lower extremities. Ascension develops products for the upper extremities using a proprietary material called PyroCarbon.

Publicly traded Integra reported sales of $732 million in 2010.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.